Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR

NCT04361448 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-02-15

No results posted yet for this study

Summary

The performance of 3 different sampling methods (2 nasopharyngeal swabs, 1 oropharyngeal swab) for the detection of SARS-CoV-2 with real-time reverse transcriptase polymerase chain reaction will be compared.

Conditions

Interventions

OTHER

samling of oropharynx and nasopharynx

Three different swabs will be taken of each participant: 1 oropharyngeal swab and 2 nasopharyngeal swabs

Sponsors & Collaborators

  • Jessa Hospital

    lead OTHER

Principal Investigators

  • Reinoud Cartuyvels · Jessa Hospital, Hasselt, Belgium

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-20
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04361448 on ClinicalTrials.gov